5 November 2025
Hogan Lovells advises MindMed in its US$259 million public offering
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Steve Abrams Lead | Hogan Lovells | Partner | Capital Markets | Philadelphia |
| Val Delp | Hogan Lovells | Counsel | Capital Markets | Philadelphia |
| Tyler Glass | Hogan Lovells | Senior associate | Capital Markets | Philadelphia |
| Spencer Leroux | Hogan Lovells | Associate | Capital Markets | Northern Virginia |
| Kayvon Paul | Hogan Lovells | Associate | Capital Markets | Philadelphia |
| Henry Kahn | Hogan Lovells | Counsel | M&A | Baltimore |
| Steven Kaufman | Hogan Lovells | Partner | M&A | Washington, D.C. |
| Caitlin Piper | Hogan Lovells | Partner | Tax, Pensions & Benefits | Washington, D.C. |
| Lynn Mehler | Hogan Lovells | Partner | Pharmaceuticals & Biotechnology | Washington, D.C. |
| Katherine Kramer | Hogan Lovells | Associate | Pharmaceuticals & Biotechnology | Not stated |
Stated terms
- Stated value
- USD 259m (US$259 million)
- What the figure measures
- Issue size
- Client
- Mind Medicine (MindMed) Inc.Issuer
- Counterparties
- Not stated